These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8583355)

  • 1. Comparison of behavioural effects of repeated treatment with methamphetamine plus scopolamine and methamphetamine alone on behavioural sensitization and conditioned response.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    J Pharm Pharmacol; 1995 Oct; 47(10):852-6. PubMed ID: 8583355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated treatment with methamphetamine plus scopolamine and methamphetamine on behavioral sensitization and conditioning.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    Behav Brain Res; 1996 Oct; 80(1-2):169-75. PubMed ID: 8905140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine plus scopolamine potentiates behavioral sensitization and conditioning.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    Eur J Pharmacol; 1995 Jun; 279(2-3):135-42. PubMed ID: 7556393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotyped behavioral responses to an auditory stimulus in the course of repeated treatment with methamphetamine plus scopolamine and methamphetamine in rats.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):169-78. PubMed ID: 7941782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral responses induced by repeated treatment with methamphetamine alone and in combination with scopolamine in rats.
    Yui K; Miura T
    Neuropsychobiology; 1996; 33(1):21-7. PubMed ID: 8821371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scopolamine prevents augmentation of stereotypy induced by chronic methamphetamine treatment.
    Ohmori T; Abekawa T; Koyama T
    Psychopharmacology (Berl); 1995 Sep; 121(2):158-63. PubMed ID: 8545520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.
    Nishikawa T; Mataga N; Takashima M; Toru M
    Eur J Pharmacol; 1983 Mar; 88(2-3):195-203. PubMed ID: 6133769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned drug effects of pimozide, haloperidol and chlorpromazine on methamphetamine-induced behavior.
    Miyamoto K
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):629-36. PubMed ID: 2074622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of scopolamine and methylscopolamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool-Hauser VA
    J Pharmacol Exp Ther; 1983 Apr; 225(1):42-9. PubMed ID: 6834276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pavlovian inhibitory conditioning and tolerance-reversal to scopolamine-induced adipsia in rats.
    Vila J; Miranda F
    Behav Neural Biol; 1994 Mar; 61(2):177-80. PubMed ID: 8204083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scopolamine prevents the development of sensitization to methamphetamine.
    Ohmori T; Abekawa T; Koyama T
    Life Sci; 1995; 56(14):1223-9. PubMed ID: 7475900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior.
    Hall DA; Stanis JJ; Marquez Avila H; Gulley JM
    Psychopharmacology (Berl); 2008 Jan; 195(4):469-78. PubMed ID: 17874316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization.
    Chen PC; Lao CL; Chen JC
    J Neurochem; 2007 Jan; 100(1):225-41. PubMed ID: 17101033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholinergic modulation on stereotyped behavior and behavioral hypersensitivity (reverse tolerance) in rats].
    Yui K; Miura T
    Yakubutsu Seishin Kodo; 1991 Apr; 11(2):141-56. PubMed ID: 1927059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of scopolamine, lorazepam, and glycopyrrolate on classical conditioning of the human eyeblink response.
    Bahro M; Schreurs BG; Sunderland T; Molchan SE
    Psychopharmacology (Berl); 1995 Dec; 122(4):395-400. PubMed ID: 8657840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization.
    Ujike H; Onoue T; Akiyama K; Hamamura T; Otsuki S
    Psychopharmacology (Berl); 1989; 98(1):89-92. PubMed ID: 2498964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pavlovian conditioning between co-administered drugs: elicitation of an apomorphine-induced antiparkinsonian response by scopolamine.
    Carey RJ
    Psychopharmacology (Berl); 1991; 104(4):463-9. PubMed ID: 1780415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
    Muraki A
    Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scopolamine impairs acquisition and facilitates consolidation of fear conditioning: differential effects for tone vs context conditioning.
    Young SL; Bohenek DL; Fanselow MS
    Neurobiol Learn Mem; 1995 Mar; 63(2):174-80. PubMed ID: 7663891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA).
    Brennan K; Johnstone A; Fitzmaurice P; Lea R; Schenk S
    Drug Alcohol Depend; 2007 May; 88(2-3):204-13. PubMed ID: 17125936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.